Talaris Therapeutics, Inc.
NASDAQ:TALS
2.72 (USD) • At close October 19, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||
| Current Assets: | ||||||||||||||||
| Cash & Cash Equivalents
| 35.33 | 30.506 | 35.008 | 70.148 | 67.083 | 18.351 | 24.224 | 13.67 | 18.468 | 25.518 | 22.791 | 18.614 | 27.311 | 36.297 | 9.889 | 17.589 |
| Short Term Investments
| 213.976 | 227.797 | 246.916 | 219.385 | 79.941 | 133.901 | 141.589 | 167.612 | 175.401 | 181.594 | 202.738 | 225.357 | 227.423 | 229.923 | 130.212 | 131.899 |
| Cash and Short Term Investments
| 249.306 | 258.303 | 281.924 | 289.533 | 147.024 | 152.252 | 165.813 | 181.282 | 193.869 | 207.112 | 225.529 | 243.971 | 254.734 | 266.22 | 140.101 | 149.488 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.477 | 0.374 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.158 | 0.813 |
| Other Current Assets
| 8.838 | 10.539 | 11.861 | 8.594 | 4.023 | 3.955 | 3.047 | 4.331 | 4.258 | 4.925 | 2.889 | 2.543 | 3.493 | 4.25 | 2.702 | 0.076 |
| Total Current Assets
| 258.144 | 268.842 | 293.785 | 298.127 | 151.047 | 156.207 | 168.86 | 185.613 | 198.127 | 212.037 | 228.418 | 246.514 | 258.227 | 270.47 | 142.803 | 150.751 |
| Non-Current Assets: | ||||||||||||||||
| Property, Plant & Equipment, Net
| 0.229 | 0.267 | 0.307 | 0.355 | 0 | 1.053 | 3.636 | 7.991 | 8.306 | 8.768 | 8.717 | 4.804 | 2.994 | 2.255 | 2.083 | 2.013 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 26 | 36.633 | 32.467 | 44.878 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 3.125 | 3.259 | 1.888 | 1.431 | 0.014 | 1.861 | 0.111 | 0.111 | 0.111 | 0.111 | 0.111 | 0.104 | 0.104 | 0.089 | 0.014 | 0.014 |
| Total Non-Current Assets
| 29.354 | 40.159 | 34.662 | 46.664 | 0.014 | 2.914 | 3.747 | 8.102 | 8.417 | 8.879 | 8.828 | 4.908 | 3.098 | 2.344 | 2.097 | 2.027 |
| Total Assets
| 287.498 | 309.001 | 328.447 | 344.791 | 151.061 | 159.121 | 172.607 | 193.715 | 206.544 | 220.916 | 237.246 | 251.422 | 261.325 | 272.814 | 144.9 | 152.778 |
| Liabilities & Equity: | ||||||||||||||||
| Current Liabilities: | ||||||||||||||||
| Account Payables
| 2.235 | 3.583 | 2.054 | 2.387 | 0.136 | 2.934 | 3.384 | 3.887 | 2.133 | 2.075 | 3.485 | 2.556 | 1.182 | 1.265 | 0.769 | 0.767 |
| Short Term Debt
| 0.196 | 0.227 | 0.226 | 0.224 | 0.634 | 0.601 | 0.751 | 0.91 | 0.905 | 0.835 | 0.74 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.048 | 0.156 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 6.349 | 0 | 0 | 0 | 0 | 3.1 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 2.956 | 1.516 | 2.95 | 1.363 | 7.335 | 6.599 | 6.044 | 6.665 | 6.13 | 4.421 | 3.84 | 5.431 | 3.8 | 3.396 | 2.764 | 2.481 |
| Total Current Liabilities
| 7.622 | 8.909 | 7.284 | 6.361 | 8.105 | 10.134 | 10.179 | 11.462 | 9.168 | 7.331 | 8.065 | 7.987 | 4.982 | 4.661 | 3.581 | 3.404 |
| Non-Current Liabilities: | ||||||||||||||||
| Long Term Debt
| 0 | 0.017 | 0.064 | 0.109 | 0 | 0.425 | 0.521 | 1.974 | 2.199 | 2.43 | 2.659 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.013 | 0.023 | 0.031 | 0.039 | 0.082 | 0.13 | 0.176 | 0.224 | 0.31 | 0.413 | 0.492 | 0.626 | 0.694 | 0.8 | 187.785 | 1.369 |
| Total Non-Current Liabilities
| 0.013 | 0.04 | 0.095 | 0.148 | 0.082 | 0.555 | 0.697 | 2.198 | 2.509 | 2.843 | 3.151 | 0.626 | 0.694 | 0.8 | 187.785 | 1.369 |
| Total Liabilities
| 7.635 | 8.949 | 7.379 | 6.509 | 8.187 | 10.689 | 10.876 | 13.66 | 11.677 | 10.174 | 11.216 | 8.613 | 5.676 | 5.461 | 191.366 | 4.773 |
| Equity: | ||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.003 | 0.003 | 0.003 | 0.003 | 0 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.001 | 0.003 |
| Retained Earnings
| -158.231 | -135.261 | -113.026 | -92.849 | -208.991 | -201.976 | -187.238 | -164.741 | -146.213 | -127.202 | -109.106 | -90.847 | -76.606 | -63.665 | -52.313 | -43.014 |
| Accumulated Other Comprehensive Income/Loss
| 0.227 | 0.296 | 0.821 | -0.452 | -0.115 | -0.214 | -0.299 | -0.721 | -1.222 | -1.143 | -0.926 | -0.078 | 0.029 | 0.034 | 0.009 | -0.013 |
| Other Total Stockholders Equity
| 437.864 | 435.014 | 433.27 | 431.58 | 351.98 | 350.618 | 349.264 | 344.792 | 342.298 | 339.083 | 336.058 | 333.652 | 332.222 | 330.98 | -0.009 | 191.029 |
| Total Shareholders Equity
| 279.863 | 300.052 | 321.068 | 338.282 | 142.874 | 148.432 | 161.731 | 180.055 | 194.867 | 210.742 | 226.03 | 242.809 | 255.649 | 267.353 | -46.466 | 148.005 |
| Total Equity
| 0 | 0 | 0 | 0 | 142.874 | 148.432 | 161.731 | 180.055 | 194.867 | 210.742 | 226.03 | 242.809 | 255.649 | 267.353 | -46.466 | 148.005 |
| Total Liabilities & Shareholders Equity
| 287.498 | 309.001 | 328.447 | 344.791 | 151.061 | 159.121 | 172.607 | 193.715 | 206.544 | 220.916 | 237.246 | 251.422 | 261.325 | 272.814 | 144.9 | 152.778 |